HADLIMA 40 MG SOL INJ CT 1 SER PREENCH VD TRANS X 0,8 ML + CAN APLIC
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1592100040021 -
GGREM
569723010000807 -
Código de barras
7898994958208
O que a fonte publica
- Detentor do registro
- SAMSUNG BIOEPIS BR PHARMACEUTICAL LTDA.
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 40 MG SOL INJ CT 1 SER PREENCH VD TRANS X 0,8 ML + CAN APLIC
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "HADLIMA 40 MG SOL INJ CT 1 SER PREENCH VD TRANS X 0,8 ML + CAN APLIC",
"holder": "SAMSUNG BIOEPIS BR PHARMACEUTICAL LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898994958208"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "569723010000807",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "24.563.776/0001-88",
"priceRegime": "Regulado",
"productName": "HADLIMA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "40 MG SOL INJ CT 1 SER PREENCH VD TRANS X 0,8 ML + CAN APLIC",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "1320.56",
"icms-12": "1500.64",
"icms-17": "1591.04",
"icms-18": "1610.44",
"icms-19": "1630.32",
"icms-20": "1650.70",
"icms-21": "1671.60",
"icms-22": "1693.03",
"icms-23": "1715.01",
"icms-17.5": "1600.68",
"icms-19.5": "1640.45",
"icms-20.5": "1661.08",
"icms-22.5": "1703.95",
"icms-12-alc": "1482.63",
"icms-17-alc": "1571.94",
"icms-18-alc": "1591.11",
"icms-19-alc": "1610.76",
"icms-20-alc": "1630.89",
"icms-21-alc": "1651.54",
"icms-22-alc": "1672.71",
"icms-23-alc": "1694.43",
"withoutTaxes": "1304.71",
"icms-17.5-alc": "1581.47",
"icms-19.5-alc": "1620.76",
"icms-20.5-alc": "1641.15",
"icms-22.5-alc": "1683.50"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1820.25",
"icms-12": "2068.48",
"icms-17": "2193.08",
"icms-18": "2219.82",
"icms-19": "2247.23",
"icms-20": "2275.32",
"icms-21": "2304.13",
"icms-22": "2333.67",
"icms-23": "2363.96",
"icms-17.5": "2206.37",
"icms-19.5": "2261.19",
"icms-20.5": "2289.63",
"icms-22.5": "2348.72",
"icms-12-alc": "2049.65",
"icms-17-alc": "2173.11",
"icms-18-alc": "2199.62",
"icms-19-alc": "2226.78",
"icms-20-alc": "2254.61",
"icms-21-alc": "2283.16",
"icms-22-alc": "2312.42",
"icms-23-alc": "2342.45",
"withoutTaxes": "1803.69",
"icms-17.5-alc": "2186.29",
"icms-19.5-alc": "2240.61",
"icms-20.5-alc": "2268.79",
"icms-22.5-alc": "2327.34"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1592100040021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:569723010000807"